A Comprehensive Review of Emerging Approaches in Machine Learning for De Novo PROTAC Design
Yossra Gharbi, Roc\'io Mercado

TL;DR
This review discusses how machine learning techniques are transforming the design of PROTACs, complex molecules used in targeted protein degradation, highlighting recent advances, challenges, and future directions in the field.
Contribution
It provides a comprehensive analysis of ML applications in de novo PROTAC design, emphasizing linker design complexities and evaluating current methodologies and limitations.
Findings
ML accelerates PROTAC development process
Fragment-based drug design informs linker optimization
Current ML methods face challenges in complex PROTAC design
Abstract
Targeted protein degradation (TPD) is a rapidly growing field in modern drug discovery that aims to regulate the intracellular levels of proteins by harnessing the cell's innate degradation pathways to selectively target and degrade disease-related proteins. This strategy creates new opportunities for therapeutic intervention in cases where occupancy-based inhibitors have not been successful. Proteolysis-targeting chimeras (PROTACs) are at the heart of TPD strategies, which leverage the ubiquitin-proteasome system for the selective targeting and proteasomal degradation of pathogenic proteins. As the field evolves, it becomes increasingly apparent that the traditional methodologies for designing such complex molecules have limitations. This has led to the use of machine learning (ML) and generative modeling to improve and accelerate the development process. In this review, we explore the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvancements in Semiconductor Devices and Circuit Design · Integrated Circuits and Semiconductor Failure Analysis · Protein Degradation and Inhibitors
